Transplantation, Homologous
"Transplantation, Homologous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals.
| Descriptor ID |
D014184
|
| MeSH Number(s) |
E04.936.864
|
| Concept/Terms |
Transplantation, Homologous- Transplantation, Homologous
- Transplantation, Allogeneic
- Homografting
- Homologous Transplantation
- Allogeneic Transplantation
- Allografting
|
Below are MeSH descriptors whose meaning is more general than "Transplantation, Homologous".
Below are MeSH descriptors whose meaning is more specific than "Transplantation, Homologous".
This graph shows the total number of publications written about "Transplantation, Homologous" by people in this website by year, and whether "Transplantation, Homologous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 7 | 7 |
| 1997 | 0 | 5 | 5 |
| 1998 | 1 | 3 | 4 |
| 1999 | 0 | 5 | 5 |
| 2000 | 2 | 0 | 2 |
| 2001 | 1 | 7 | 8 |
| 2002 | 1 | 16 | 17 |
| 2003 | 1 | 10 | 11 |
| 2004 | 1 | 8 | 9 |
| 2005 | 2 | 14 | 16 |
| 2006 | 3 | 9 | 12 |
| 2007 | 4 | 15 | 19 |
| 2008 | 0 | 17 | 17 |
| 2009 | 1 | 11 | 12 |
| 2010 | 3 | 13 | 16 |
| 2011 | 0 | 19 | 19 |
| 2012 | 3 | 24 | 27 |
| 2013 | 1 | 14 | 15 |
| 2014 | 2 | 15 | 17 |
| 2015 | 1 | 18 | 19 |
| 2016 | 0 | 11 | 11 |
| 2017 | 3 | 6 | 9 |
| 2018 | 2 | 19 | 21 |
| 2019 | 2 | 16 | 18 |
| 2020 | 0 | 15 | 15 |
| 2021 | 0 | 13 | 13 |
| 2022 | 0 | 7 | 7 |
| 2023 | 0 | 8 | 8 |
| 2024 | 2 | 8 | 10 |
| 2025 | 0 | 9 | 9 |
| 2026 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transplantation, Homologous" by people in Profiles.
-
Risk biomarkers of chronic GVHD in children aged 10 years or younger and children/adults older than 10 years. Blood Adv. 2026 Jan 13; 10(1):168-180.
-
Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT. Bone Marrow Transplant. 2026 Jan; 61(1):36-43.
-
HLA matching or CRISPR editing of HLA class I/II enables engraftment and effective function of allogeneic human regulatory T cell therapy in a humanized mouse transplantation model. Nat Commun. 2025 Oct 13; 16(1):9090.
-
Osteochondral Allograft Transplantation for Large Osteochondral Lesions of the Femoral Head in Young Patients. J Pediatr Orthop. 2025 Oct 01; 45(9):e826-e831.
-
Allogeneic versus autologous stem cell transplantation after relapsing following first line autologous transplantation for multiple myeloma: A systematic review. Cancer. 2025 May 15; 131(10):e35896.
-
Impacts of donor age and HLA mismatch on HCT outcomes differ according to the donor CMV serostatus in unrelated allo-HCT. Blood Adv. 2025 May 13; 9(9):2356-2365.
-
Improved outcomes of acute lymphoblastic leukemia after allogeneic blood or marrow transplantation with highdose post-transplantation cyclophosphamide in the era of more effective pre-transplant therapy. Haematologica. 2025 Nov 01; 110(11):2635-2646.
-
Pulmonary function testing in pediatric allogeneic stem cell transplant recipients to monitor for Bronchiolitis obliterans syndrome: a systematic review. BMC Pediatr. 2025 Mar 28; 25(1):250.
-
Fludarabine Plus Myeloablative Dose of Busulfan Regimen Was Associated with High Nonrelapse Mortality in Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Lymphoma: A Propensity Score-Matched Comparison Study with Fludarabine Plus High-Dose Melphalan. Transplant Cell Ther. 2025 Jun; 31(6):382.e1-382.e17.
-
Increased Non-Relapse Mortality in Older People With Allogeneic Hematopoietic Stem Cell Transplantation Using Fludarabine and Myeloablative Dose of Busulfan-Based Regimen. Eur J Haematol. 2025 May; 114(5):852-863.